Life sciences software & AI news

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Showing 1000+ results
A minimalist illustration of a heart rate monitor in a dark color scheme.

Jun 12, 2026

US Digital Health Market Size, Share, Growth | CAGR of 19.6%

The U.S. digital health market is poised for remarkable growth, projected to expand from $94.8 billion in 2024 to approximately $567.7 billion by 2034, reflecting a compound annual growth rate (CAGR) of 19.6% during this period.This surge in the digital health sector is primarily driven by the increasing adoption of connected healthcare technologies and a rising demand for remote patient monitoring solutions. The integration of telehealth platforms, mobile health applications, wearables, and AI-
An industrial policy document and pencil on a conference table in a dimly lit room.

Jun 12, 2026

Europe’s innovation challenge

Nobel laureate Philippe Aghion emphasizes the need for Europe to enhance its industrial policy, particularly in the realm of artificial intelligence (AI), to remain competitive globally. He argues that current trends show long-term institutional investors, like pension funds, are predominantly channeling their AI investments into the U.S., highlighting a significant gap in Europe’s strategic approach.Aghion, a professor at the London School of Economics and other prestigious institutions, spoke
A minimalist illustration of a cloud and a virtual twin figure in a dark palette.

Jun 12, 2026

Dassault partners with PariSanté Campus on health AI

Dassault Systèmes has formed a partnership with PariSanté Campus to bolster healthcare startups in Europe, focusing on the integration of AI and digital health innovations.This collaboration merges Dassault’s expertise in virtual twins and cloud technologies with PariSanté Campus, a leading French innovation hub for health-related digital advancements. The initiative aims to provide startups with essential resources, including access to AI capabilities and sovereign cloud infrastructure, enablin
A minimalist illustration of a semiconductor chip and an AI neural network node on a dark background.

Jun 12, 2026

Asia's Biggest Startup Funding Rounds: Week 24, 2026

This week, Asia's startup funding landscape was dominated by significant investments in infrastructure technologies, particularly in sectors like semiconductors, AI, electric mobility, and biotechnology, totaling over $185 million.Among the standout funding rounds, Singapore's Silicon Box led with $77.5 million aimed at expanding its semiconductor packaging capabilities. Following closely, India's Innefu Labs secured $30 million to enhance its AI platforms for national security applications, mar
A blood sample tube with CAR-T cells in a clinical lab setting

Jun 12, 2026

Legend Biotech (LEGN) Is Up 6.1% After Early In Vivo CAR-T Data for LB2501 – What's Changed

Legend Biotech has recently reported promising early Phase 1 data for its investigational CAR-T therapy, LB2501, which targets both CD19 and CD20 in patients with relapsed or refractory B-cell non-Hodgkin lymphoma. The initial findings indicate high response rates, enhanced CAR-T cell expansion proportional to dosage, and a manageable safety profile, all achieved without the need for lymphodepleting chemotherapy.This innovative approach of generating CAR-T cells within the patient from a single
A stethoscope and speech bubble representing AI in healthcare conversations.

Jun 12, 2026

Nvidia & Abridge Join Forces to Build AI Healthcare Model for Clinical Conversations

Nvidia and Abridge are collaborating to create an AI Healthcare Model aimed at enhancing clinical conversations between healthcare providers and patients.This partnership merges Nvidia’s advanced Nemotron open models with Abridge’s expertise in clinical data and de-identified healthcare information. The goal is to develop a system that comprehensively processes the nuances of clinician-patient interactions. According to Kimberly Powell, Nvidia’s VP of Healthcare, this collaboration allows for th
X-ray machine in a hospital radiology room

Jun 12, 2026

UK Govt Commits EUR 20 Mn to Expand AI X-ray Tools Across NHS by 2029

The UK government has announced a significant investment of EUR 20 million to implement AI X-ray tools across all NHS trusts in England by 2029, aiming to enhance cancer diagnosis and expedite the identification of serious health conditions.This funding initiative is part of a broader strategy to transition the NHS from traditional methods to digital technologies. Early data indicates that radiologists using AI can review scans in an average of four days, a notable improvement from the previous
A pill bottle and prescription pad on a wooden desk in a clinical setting.

Jun 12, 2026

Ildong Pharmaceutical Stock (KR7249420008): AI Therapeutics Deal With Welt Puts Digital Health In Fo

Ildong Pharmaceutical has recently gained attention by signing a memorandum of understanding with digital health firm Welt to develop AI-powered digital therapeutics. This strategic partnership aims to integrate Ildong's pharmaceutical offerings with Welt's DrugOS AI platform, enhancing patient monitoring and adherence throughout treatment. The collaboration underscores Ildong's initiative to explore new growth opportunities in the increasingly competitive South Korean pharmaceutical landscape.T
A flat illustration of a drug molecule on a solid background.

Jun 12, 2026

AI and Automation Reshape Biotech... Global Investment in Innovative Biopharma Technologies Expands

The integration of artificial intelligence (AI) and automation is significantly altering investment dynamics in the pharmaceutical and biotechnology sectors, as companies strive to enhance efficiency and accuracy in research and development.Recent developments indicate that major players are intensifying their efforts to leverage these technologies. Samsung Electronics, for instance, has made a substantial investment in Element Biosciences, securing a $175 million stake to become its largest sha
A vial of clear liquid on a lab bench in a dimly lit laboratory setting.

Jun 12, 2026

Failed Obesity Trial And Investor Exit Might Change The Case For Investing In Wave Life Sciences (WVE)

Wave Life Sciences faces significant challenges following the failure of its obesity treatment, WVE-007, and the exit of a key investor, Exome Asset Management. This situation has intensified scrutiny on the company’s future strategic direction and resource allocation.The disappointing results from the WVE-007 trial have raised concerns regarding Wave's RNA-based pipeline, compelling management to prioritize its remaining programs, particularly those targeting alpha-1 antitrypsin deficiency (AAT
A syringe and vial in a hospital lab setting

Jun 12, 2026

KFSH Advances Practical AI Applications Driving Transformation Across Specialized Healthcare

King Faisal Specialist Hospital & Research Centre (KFSH) is set to showcase its innovative use of artificial intelligence at HLTH Europe 2026, demonstrating a shift from experimental projects to practical applications that enhance healthcare delivery.The hospital's Centre for Healthcare Intelligence, established in 2019, has been pivotal in developing 20 AI applications aimed at improving medical image analysis, patient flow, and resource management. These advancements are designed to enhance tr
A tube of acne treatment cream on a pharmacy shelf at dusk.

Jun 12, 2026

Glenmark Pharma Rolls Out New Acne Treatment in Europe

Glenmark Pharmaceuticals has introduced Winlevi, a new acne treatment cream, in various European markets, marking a significant shift towards specialized dermatological products.Glenmark's launch of Winlevi (clascoterone 10 mg/g cream) is a notable milestone, as it's the company's first release of a New Chemical Entity (NCE) in Europe. Managed through Glenmark Specialty SA, the rollout spans key regions, including the Nordic countries, Central and Eastern Europe, and Spain, with a partnership in